Toxicological screening for over 1000 compounds in an MRM based acquisition for Library ID in whole blood samples

Significance of the Topic

The development of a comprehensive screening method for over 1000 toxicologically relevant compounds in whole blood addresses key challenges in clinical and forensic analysis. Employing an MRM-based acquisition with library identification reduces false positives and negatives while enabling simultaneous quantification and confirmation in a single workflow.

Objectives and Study Overview

This study aimed to construct a spectral library for 1222 compounds using MRM Spectrum mode and to evaluate its performance in routine whole blood screening. The goals included method simplification, high throughput analysis, and accurate compound identification and quantitation.

Methodology and Instrumentation

The screening workflow applied a QuEChERS extraction protocol to whole blood samples followed by UHPLC-MS/MS analysis. Chromatography was performed on a biphenyl column with a 17-minute binary gradient and flow rate of 0.3 mL per minute. Mass spectrometric data were acquired on a triple quadrupole LCMS-8060 using heated electrospray ionization and an MRM Spectrum mode. This mode captured multiple precursor-to-fragment transitions per analyte, each with optimized collision energy, generating high fidelity product ion spectra.

Instrumentation Used

• UHPLC: Nexera LC system with Restek Raptor Biphenyl 2.7 µm column at 50 °C
• MS/MS: Shimadzu LCMS-8060 with Heated ESI, 15 000 u per second scan speed
• MRM Settings: up to six transitions per compound, 1 ms dwell and pause times, polarity switching in 5 ms

Main Findings and Discussion

MRM Spectrum mode produced dense fragmentation data enabling library matching with similarity scores typically above 98. Quantitative performance matched conventional two-transition methods, with calibration curves showing R2 values greater than 0.99. Patient sample analyses successfully identified and quantified therapeutic and illicit compounds—such as benzoylecgonine, morphine, buprenorphine, oxazepam, nordiazepam, and temazepam—demonstrating accurate concentrations and high confidence identification.

Benefits and Practical Applications

• Combined quantitative and qualitative screening in a single run
• Reduced method development time and simplified workflows
• High confidence compound identification through library matching
• Wide coverage of clinical and forensic analytes in whole blood

Future Trends and Opportunities

Advancements may include expansion of spectral libraries, integration with high-resolution instruments for enhanced selectivity, automation of data processing using artificial intelligence, and miniaturized or point-of-care platforms for rapid toxicological screening.

Conclusion

MRM Spectrum mode with a large fragment ion library provides a robust, high-throughput solution for toxicological screening in whole blood. It delivers reliable quantitation equivalent to traditional methods while enhancing identification confidence and simplifying laboratory workflows.

References

No specific literature references were provided in the original document.